期刊
CURRENT DRUG TARGETS
卷 22, 期 5, 页码 505-538出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389450121999200819144544
关键词
Alzheimer's disease; structure-activity relationship; multi-target-directed ligands; acetylcholinesterase; nicotinic acetylcholine receptors; synthetic routes
资金
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]
- CNPq [454088/2014-0, 400271/2014-1, 310082/2016-1]
- FAPEMIG [CEX-APQ-00241-15]
- Sao Paulo Research Foundation (FAPESP) [2018/00187-7]
This article summarizes the therapeutic targets, drugs, and synthetic routes involved in Alzheimer's disease, as well as some bioactive compounds under development to illustrate recent research advances in medicinal chemistry. The importance of multi-target approaches, including examples from research projects, is emphasized to guide the search for more effective drug candidates. This review covers the period between 2001 and early 2020.
We describe herein the therapeutic targets involved in Alzheimer's disease as well as the available drugs and their synthetic routes. Bioactive compounds under development are also exploited to illustrate some recent research advances on the medicinal chemistry of Alzheimer's disease, including structure-activity relationships for some targets. The importance of multi-target approaches, including some examples from our research projects, guides new perspectives in search of more effective drug candidates. This review comprises the period between 2001 and early 2020.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据